Cambrex to Announce Third Quarter 2009 Financial Results on November 3, 2009

EAST RUTHERFORD, N.J., Oct. 27 Cambrex Corporation (NYSE: CBM) announced that third quarter 2009 financial results will be released on Tuesday, November 3, 2009 after the market closes.

The Company will host a conference call to discuss the third quarter 2009 financial results.

About Cambrex

Cambrex provides products and services to accelerate the development and commercialization of small molecule therapeutics including active pharmaceutical ingredients ("API"), advanced intermediates, enhanced drug delivery, and other products for branded and generic pharmaceuticals. For more information, please visit www.cambrex.com.

Third Quarter 2009 Earnings Conference Call When: Wednesday, November 4, 2009 at 8:30 a.m. Eastern Time Dial-in: 1-888-634-4003 for U.S. 1-706-634-6653 for International Pass code: 37211896 Dial-in Replay: 1-800-642-1687 for U.S. 1-706-645-9291 for International Pass code: 37211896 Available through Wednesday, November 11, 2009 Webcast: www.cambrex.com Available for 30 days following the conference call

SOURCE Cambrex Corporation

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...